Want to join the conversation?
Biopharmaceutical company $AMGN said the US FDA has issued a Complete Response Letter for the NDA for Parsabiv for treating secondary hyperparathyroidism in adult patients with chronic kidney disease on hemodialysis. Company is reviewing the letter, and anticipates a post-action meeting with the FDA later this year to discuss the response.
$FOXA just entered into a preliminary deal with Sky plc under which it will acquire all shares, or should I say remaining shares for a total value of $23 billion. The sleeping fox catches no poultry, but this fox just caught something that’s a lot bigger than poultry.
$BIG looks promising to me. Feels like it’s a good time to put some money on it.
$TWTR rolled out an iOS update Dec. 8 night that killed its famous "@" symbol. This lead to confusion among the iOS users when they tried it to reply to tweets.